m, Do you have any evidence that Prana has complied with the FDA's request of last year to submit evidence of safety to aid them in lifting the partial clinical hold? It is my opinion that many former shareholders including the institutions and funds have not returned due to the fact that the roadblock is in Prana's hands.
There have been many opportunities throughout the years for PBT2 to prove itself through the drug regulatory process. Prana has not been successful in convincing any regulators, not only the FDA, of the usefulness of PBT2 or any other product.
BTW it might serve better to not concentrate solely on Biogen and the amyloid beta theory as Prana's only competitor. There is much more current work progressing in the rest of the scientific world. That information is easily found in professional medical and business literature. It's changing daily.
- Forums
- ASX - By Stock
- ATH
- Fargas likely gone
Fargas likely gone, page-48
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
-0.001(25.0%) |
Mkt cap ! $15.96M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.3¢ | $4.734K | 1.341M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
49 | 30295639 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 129917446 | 34 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
49 | 30295639 | 0.003 |
56 | 92253933 | 0.002 |
26 | 130210099 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 129917446 | 34 |
0.005 | 17146205 | 20 |
0.006 | 14731534 | 14 |
0.007 | 52406651 | 23 |
0.008 | 39354483 | 30 |
Last trade - 15.44pm 15/10/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |
The Watchlist
JBY
JAMES BAY MINERALS LIMITED
Andrew Dornan, Executive Director
Andrew Dornan
Executive Director
SPONSORED BY The Market Online